Dermal Fillers and Botulinum Toxin Market

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.

Dermal Fillers and Botulinum Toxin Market contains market size and forecasts of Dermal Fillers and Botulinum Toxin in global, including the following market information:

Global Dermal Fillers and Botulinum Toxin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dermal Fillers and Botulinum Toxin Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Dermal Fillers and Botulinum Toxin companies in 2021 (%)

The global Dermal Fillers and Botulinum Toxin market was valued at 12400 million in 2021 and is projected to reach US$ 30250 million by 2028, at a CAGR of 13.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dermal Fillers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dermal Fillers and Botulinum Toxin include Allergan, Galderma, LG Life Science, Merz, Medytox, Bloomage, Bohus BioTech, Sinclair Pharma and IMEIK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Dermal Fillers and Botulinum Toxin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dermal Fillers and Botulinum Toxin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, by Type, 2021 (%)

• Dermal Fillers
• Botulinum Toxin

Global Dermal Fillers and Botulinum Toxin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, by Application, 2021 (%)

• Medical
• Cosmetic

Global Dermal Fillers and Botulinum Toxin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dermal Fillers and Botulinum Toxin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Dermal Fillers and Botulinum Toxin revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Dermal Fillers and Botulinum Toxin revenues share in global market, 2021 (%)
• Key companies Dermal Fillers and Botulinum Toxin sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Dermal Fillers and Botulinum Toxin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Galderma
• LG Life Science
• Merz
• Medytox
• Bloomage
• Bohus BioTech
• Sinclair Pharma
• IMEIK
• Suneva Medical
• Teoxane
• Luminera
• SciVision Biotech
• Haohai Bio
• Ipsen
• LIBP
• US World Meds
• Hugel
• Daewoong